))
Drugs Cheaper Than Beer — with Brian Finrow
Manage episode 490594399 series 3665177
Content provided by Ross Rheingans-Yoo. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Ross Rheingans-Yoo or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
I'm joined this week by Brian Finrow, CEO of Lumen Bioscience, who thinks we would be better off if we grew more drugs in algae, and fewer in Chinese Hamster Ovary cells.
We talk about why "monoclonal antibodies" are particularly safe and effective as drugs—but incredibly expensive to manufacture—and whether the fundamental problem of the biotech industry is that everyone just has too much money.
Full transcript at https://developmentandresearch.bio/episode/brian-finrow/
5 episodes
Share
